EPCAM and posterior cortical atrophy: EpCAM is a type I transmembrane glycoprotein overexpressed in most PCa tumors and metastases,62 and EpCAM-targeting CAR T cells have proceeded to a clinical trial that is ongoing (NCT03013712).